Chabiotech Co.,Ltd. (KOSDAQ:085660)

Chabiotech Revenue

Chabiotech had revenue of 316.43B KRW in the quarter ending June 30, 2026, with 5.87% growth. This brings the company's total for the last twelve months to 1.31T, up 13.93% year-over-year. In the year 2025, Chabiotech had annual revenue of 1.27T with 21.36% growth. That makes Chabiotech the 7,728th largest company in the world by revenue and 346th in South Korea.

• Revenue (ttm): 1.31T
• Revenue Growth: +13.93%
• P/S Ratio: 0.48
• Revenue / Employee: 4.43B
• Employees: 296
• Market Cap: 630.87B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Health Care 1.20T 93.6%
• Other 67.79B 5.3%
• Finance 13.74B 1.1%

By Geography

Chart

• United States of America 802.36B 62.7%
• South Korea 275.14B 21.5%
• Singapore 196.89B 15.4%
• Japan 4.94B 0.4%

Fiscal year ended Dec 31, 2025 See the full Chabiotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.27T	223.20B	21.36%
Dec 31, 2024	1.05T	91.10B	9.55%
Dec 31, 2023	953.95B	109.37B	12.95%
Dec 31, 2022	844.58B	117.11B	16.10%
Dec 31, 2021	727.48B	62.76B	9.44%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error